Biochemically altered human erythrocytes as a carrier for targeted delivery of primaquine: an in vitro study
Fars K. Alanazi, Gamal El-Din I. Harisa, Ahmad Maqboul, Magdi, Abdel-Hamid, Steven H. Neau, Ibrahim A. Alsarra

TL;DR
This study explores using human erythrocytes as carriers for targeted delivery of primaquine, examining loading efficiency, biochemical effects, and sustained drug release in vitro, with implications for targeted malaria treatment.
Contribution
It demonstrates successful loading of primaquine into erythrocytes and characterizes associated biochemical and physiological changes, advancing erythrocyte-based drug delivery methods.
Findings
Successful primaquine loading into erythrocytes with high entrapment ratios
Significant oxidative stress and membrane alterations in loaded erythrocytes
Sustained drug release over 48 hours from loaded erythrocytes
Abstract
The aim of this study was to investigate human erythrocytes as a carrier for targeted drug delivery of primaquine (PQ). The process of PQ loading in human erythrocytes, as well as the effect of PQ loading on the oxidative status of erythrocytes, was also studied. At PQ concentrations of 2, 4, 6, and 8 mg/mL and an incubation time of 2 h, the ratios of the concentrations of PQ entrapped in erythrocytes to that in the incubation medium were 0.515, 0.688, 0.697 and 0.788, respectively. The maximal decline of erythrocyte reduced glutathione content was observed at 8 mg/mL of PQ compared with native erythrocytes p < 0.001. In contrast, malondialdehyde and protein carbonyl were significantly increased in cells loaded with PQ (p < 0.001). Furthermore, osmotic fragility of PQ carrier erythrocytes was increased in comparison with unloaded cells. Electron microscopy revealed spherocyte formation…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
